Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
note decreased » rate decreased (Expand Search), costs decreased (Expand Search), cost decreased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), mean decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
note decreased » rate decreased (Expand Search), costs decreased (Expand Search), cost decreased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), mean decrease (Expand Search)
-
641
-
642
-
643
-
644
-
645
-
646
-
647
-
648
-
649
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”
-
650
-
651
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”
-
652
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”
-
653
-
654
-
655
-
656
-
657
-
658
-
659
-
660